March 14, 2018 / 11:30 AM / in 3 months

BRIEF-Merus Says Ono Pharma Exercised Option For New Research And License Agreement

March 14 (Reuters) - Merus Nv:

* MERUS ANNOUNCES ONO PHARMACEUTICALS EXERCISE OF ITS OPTION FOR NEW RESEARCH AND LICENSE AGREEMENT TO GENERATE BISPECIFIC ANTIBODY TARGETING AUTOIMMUNE DISEASES

* MERUS NV - ‍ONO HAS AGREED TO FUND RESEARCH ACTIVITIES AT MERUS THAT WILL GENERATE CANDIDATE BICLONICS FOR NEW PROGRAM​

* MERUS NV - ‍MERUS GRANTED ONO WORLDWIDE EXCLUSIVE RIGHTS TO DEVELOP, MANUFACTURE, AND COMMERCIALIZE RESULTING PRODUCTS DEVELOPED THROUGH COLLABORATION​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below